Filter
78
Filtered Results: 78
Text search:
Ramanathan,
K.
Featured
Recommendations
10
New Publications
6
Language
Document type
Studies & Reports
34
No document type
26
Guidelines
13
Manuals
3
Training Material
1
Strategic & Response Plan
1
Countries / Regions
Global
9
India
6
Brazil
4
Mozambique
2
Guinea-Bissau
2
Angola
2
Nepal
1
Kenya
1
Burkina Faso
1
USA
1
Asia
1
Latin America and the Carribbean
1
Uganda
1
Russia
1
Botswana
1
Indonesia
1
Authors & Publishers
Publication Years
Category
Countries
19
Public Health
6
Clinical Guidelines
3
Women & Child Health
3
Key Resources
2
Pharmacy & Technologies
1
Toolboxes
Planetary Health
14
COVID-19
12
TB
7
Health Financing Toolbox
7
HIV
6
Mental Health
4
AMR
4
Caregiver
3
Pharmacy
2
NCDs
2
Refugee
1
Ebola & Marburg
1
Conflict
1
Polio
1
Global Health Education
1
BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...
Four initiatives have estimated the value of aid for reproductive, maternal, newborn, and child health
(RMNCH): Countdown to 2015, the Institute for Health Metrics and Evaluation (IHME), the Muskoka Initiative, and
the Organisation for Economic Co-operation and Development (OECD) policy marker. We...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
Настоящее руководство «Клиническое ведение случаев COVID-19» базируется на
вышеуказанных стратегических приоритетах и адресовано клиницистам, участвующим в
оказа...
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
Lancet Oncol 2018 Published Online September 12, 2018 http://dx.doi.org/10.1016/S1470-2045(18)30447-9
Resumo: o que é esta orientação dinâmica?
Pergunta clínica: qual é o papel dos medicamentos na prevenção da COVID-19?
Público-alvo: o público-alvo são os médicos e os tomadores de decisão na área da saúde.
Prática atual: o uso atual de medicamentos para prevenção da COVID-19 é ...
Clincial Practice Guidelines
Update, 23 de junio de 2022
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
Frontiers in Pediatrics | www.frontiersin.org
1 April 2019 | Volume 7 | Article 159
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
